Please login to the form below

Not currently logged in
Email:
Password:

Valtrex

This page shows the latest Valtrex news and features for those working in and with pharma, biotech and healthcare.

GSK holds on to older products

GSK holds on to older products

£185m. Other products in GSK's established portfolio with declining sales include antidepressant Seroxat/Paxil (paroxetine) and antiviral drug Valtrex (valacyclovir), both of which had a double digit fall in revenues

Latest news

  • GSK back in profit for Q2

    In its report, GSK offered an 'underlying' sales performance, which excluded these products, as well as herpes treatment Valtrex (valacyclovir).

  • GSK sales fall for first quarter of 2011

    The company said the decrease in sales was mainly due to a fall in demand for its pandemic flu products; generic competition for herpes treatment Valtrex (valaciclovir); and increased restrictions in

  • Avandia damages GSK Q3 results

    Herpes treatment, Valtrex (valacyclovir fydrochloride) also saw a significant fall in sales, with generic competition in Europe and the US leading to a 75 per cent loss. ... Speaking on the company's performance, Andrew Witty, CEO, GSK, said: "Comparison

  • Q2 net loss for GSK

    Sales in the US were impacted by individual factors and adverse prior year comparisons, such as an acceleration of generic competition to Valtrex (valacyclovir), the temporary suspension of Rotarix (rotavirus vaccine),

  • S&H appoints director of account services

    John left S&H for a short stint at DraftFCB, where he was the lead account person on Cialis (tadalafil) and Valtrex (valacyclovir).

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics